Insider sales are modest relative to market cap and follow a strong earnings beat, but the CFO's sale and the director's large derivative exercise/sale pattern warrant monitoring for any future insider sales or changes in guidance.
XNCR drugs
XNCR drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 13 $37.09entry
- T+1 · 20h ago −4.56%α −2.65% · $35.40
- T+5 · in 3d Pending
- T+20 · in 27d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two Xencor insiders, including the CFO, sold a combined $3.15M in open-market stock during the week following Q3 earnings that beat consensus on milestone/royalty revenue. Director Ranieri exercised multiple derivative tranches and sold 70K shares, while CFO Cornelissen sold 10K shares. The sales total ~0.1% of market cap, a modest but notable insider cluster.
Key Financial Metrics
Key Facts
- CFO Cornelissen sold 10,100 shares for $402K on 2026-11-11 (open-market, no 10b5-1 plan)
- Director Ranieri exercised multiple derivative tranches and sold 81,252 shares for $3.19M on 2026-11-10 (open-market, no 10b5-1 plan)
- Total open-market sales: $3.15M, approximately 0.1% of XNCR's $3.0B market cap
- Sales occurred 6-7 days after Q3 2026 earnings beat (revenue $116.5M vs consensus $63.0M, EPS $0.50 vs consensus -$0.34)
- Q3 beat was largely non-operational, driven by $25M Astellas milestone and $52.5M Alexion settlement
Financial Impact
Open-market sales of $3.15M, ~0.1% of market cap
Risk Factors
- CFO selling shortly after earnings may signal personal portfolio rebalancing or limited confidence in sustained share price
- Director Ranieri exercised multiple low-strike derivatives and sold a large block, which could indicate a desire to monetize options rather than hold shares
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-XNCR-1794525322412 |
Track record
20 reports on XNCR
4 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +67.24% at T+60 after the May 5, 2026 report. 5 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $35.40 Now $35.40 +0.00% settles Nov 18
- Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $39.23 Now $35.40 −9.77% settles Nov 17
- Nov 12, 20264d ago Insider Cluster Neutral 4/10 Viewing Entry $37.09 to $35.40 Now $35.40 −4.56% ▼ −4.56% −2.65% vs SPY
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $38.13 to $37.09 Now $35.40 −7.16% ▼ −2.73% −2.36% vs SPY
- Nov 10, 20266d ago 144 Neutral 3/10 Entry $39.97 to $38.13 Now $35.40 −11.43% ▼ −4.60% −4.25% vs SPY
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $35.75 to $38.59 Now $35.40 −0.98% ▲ +7.94% +5.58% vs SPY
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $34.05 to $35.75 Now $35.40 +3.96% ▲ +4.99% +4.68% vs SPY
- Oct 30, 202617d ago SC 13G/A Bearish 4/10 Entry $29.82 to $29.66 Now $35.40 −18.71% ▲ +0.54% +0.06% vs SPY
- Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $29.99 to $29.21 Now $35.40 +18.04% ▼ −2.60% −2.22% vs SPY
- Oct 26, 202621d ago 8-K Bullish 6/10 Entry $29.18 to $29.99 Now $35.40 +21.32% ▲ +2.78% +2.22% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers